These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1854979)
1. Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial. Frisell J; Eklund G; Hellström L; Lidbrink E; Rutqvist LE; Somell A Breast Cancer Res Treat; 1991 Mar; 18(1):49-56. PubMed ID: 1854979 [TBL] [Abstract][Full Text] [Related]
2. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial. Frisell J; Lidbrink E; Hellström L; Rutqvist LE Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870 [TBL] [Abstract][Full Text] [Related]
3. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511 [TBL] [Abstract][Full Text] [Related]
4. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907 [TBL] [Abstract][Full Text] [Related]
6. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. Jonsson H; Nyström L; Törnberg S; Lenner P J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556 [TBL] [Abstract][Full Text] [Related]
7. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Swedish Organised Service Screening Evaluation Group Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening with mammography: overview of Swedish randomised trials. Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941 [TBL] [Abstract][Full Text] [Related]
9. Mammography in symptomatic and asymptomatic patients. Stomper PC; Gelman RS Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492 [TBL] [Abstract][Full Text] [Related]
10. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization. Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277 [TBL] [Abstract][Full Text] [Related]
11. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts. Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766 [TBL] [Abstract][Full Text] [Related]
12. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
13. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update. Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708 [TBL] [Abstract][Full Text] [Related]
14. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897 [TBL] [Abstract][Full Text] [Related]
15. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087 [TBL] [Abstract][Full Text] [Related]
16. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331 [TBL] [Abstract][Full Text] [Related]
17. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005 [TBL] [Abstract][Full Text] [Related]
18. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Miller AB; Baines CJ; To T; Wall C CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088 [TBL] [Abstract][Full Text] [Related]
19. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276 [TBL] [Abstract][Full Text] [Related]